Monday, December 24, 2012 4:47:16 PM
http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy
Page 11 of 23
Clinical trials in brain tumors
IND No. 10206
Glioblastoma (brain cancer)
Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment
of glioblastoma multiforme.
A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma
Multiforme
Your contact:
Prof. Dr. Michael Sabel
Michael.Sabel @ med.uni-duesseldorf.de
Page 12
Current clinical studies at University Cancer Center UTZ
University Cancer Center UTZ
Info Phone: 0211-8108200
at the University Hospital Dusseldorf
www.uniklinik-duesseldorf.de/utz
Stand: 01/2013
Page 12 of 23
Clinical trials in brain tumors
Fraunhofer Institute
Glioblastoma (brain cancer)
Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for
Treatment of glioblastoma multiforme (GBM)
Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma
multiforme (GBM)
Your contact:
Infoline
Tel: 0211-8108200
uta@med.uni-duesseldorf.de
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM